Glaucoma Community Care: Does Ongoing Shared Care Work?
chronic eye disease
collaborative care
task-shifting
telemedicine
Journal
International journal of integrated care
ISSN: 1568-4156
Titre abrégé: Int J Integr Care
Pays: England
ID NLM: 101214424
Informations de publication
Date de publication:
07 Aug 2020
07 Aug 2020
Historique:
entrez:
1
9
2020
pubmed:
31
8
2020
medline:
31
8
2020
Statut:
epublish
Résumé
We assessed a novel, public, vertical integrated care model for glaucoma management in the community. This study was a retrospective, longitudinal study of 266 patients diagnosed or suspected of glaucoma. Patients were stratified to either ongoing ophthalmology-led (n = 81) or optometry-led shared care (n = 185). Demographics and clinical characteristics, including the re-referral rate and timeliness of follow up were analysed. Just under half (565/1224, 46%) of all follow up consultations over the total study period of 45 months were seen in optometry-led care, with a re-referral rate to ophthalmology of 21%. Treated patients showed a median intraocular pressure reduction of 20% and a median time delay of just two days between the actual and recommended review period. Shared care provides an effective option for managing the ongoing care burden in chronic stable glaucoma cases at low risk of vision loss.
Identifiants
pubmed: 32863803
doi: 10.5334/ijic.5470
pmc: PMC7427692
doi:
Types de publication
Journal Article
Langues
eng
Pagination
5Informations de copyright
Copyright: © 2020 The Author(s).
Déclaration de conflit d'intérêts
The authors have no competing interests to declare.
Références
Eye (Lond). 2012 Apr;26(4):564-7
pubmed: 22222263
Br J Ophthalmol. 2000 May;84(5):456-63
pubmed: 10781507
Br J Ophthalmol. 2006 May;90(5):579-85
pubmed: 16622087
J Glaucoma. 2017 Aug;26(8):702-707
pubmed: 28617721
Clin Exp Ophthalmol. 2014 Mar;42(2):107-17
pubmed: 24224662
Eye (Lond). 2017 May;31(5):771-775
pubmed: 28128796
Clin Exp Ophthalmol. 2019 Aug;47(6):798-799
pubmed: 30801932
Aust Health Rev. 2018 Jun;42(3):286-293
pubmed: 28355525
Br J Ophthalmol. 2018 Jul;102(7):911-915
pubmed: 29074497
Ophthalmic Physiol Opt. 2015 Mar;35(2):212-24
pubmed: 25684127
Can J Ophthalmol. 2017 Jun;52(3):283-286
pubmed: 28576210
Clin Exp Ophthalmol. 2015 Jul;43(5):480-3
pubmed: 25491715
Can J Ophthalmol. 2007 Feb;42(1):34-8
pubmed: 17361238
Curr Opin Ophthalmol. 2017 Mar;28(2):127-132
pubmed: 27828895
Clin Exp Ophthalmol. 2018 Sep;46(7):826-828
pubmed: 29498181
Clin Exp Optom. 2018 Jan;101(1):90-99
pubmed: 28718219
Eye (Lond). 2012 Jun;26(6):853-61
pubmed: 22498794
Clin Exp Ophthalmol. 2015 May-Jun;43(4):308-19
pubmed: 25362898
Eye (Lond). 2010 Feb;24(2):265-9
pubmed: 19498452
Eye (Lond). 2012 Oct;26(10):1288-94
pubmed: 22766539
Ophthalmic Physiol Opt. 2011 Mar;31(2):168-73
pubmed: 21309803
Acta Ophthalmol. 2013 Aug;91(5):406-12
pubmed: 23066646
Eye (Lond). 2012 Nov;26(11):1412-7
pubmed: 22935671
Eye (Lond). 2017 Jun;31(6):899-905
pubmed: 28211881
Clin Ophthalmol. 2015 Oct 15;9:1915-23
pubmed: 26508830
Int J Integr Care. 2019 Nov 06;19(4):5
pubmed: 31749669
Ophthalmic Physiol Opt. 2016 Sep;36(5):545-57
pubmed: 27580754
J Glaucoma. 2016 Apr;25(4):e392-400
pubmed: 26550976
Ophthalmic Physiol Opt. 2016 Nov;36(6):632-642
pubmed: 27790767
Br J Ophthalmol. 2007 Dec;91(12):1639-43
pubmed: 17537783